We came across a bullish thesis on Natera on Base by Base's Substack by Edward Larkin. As of 9ᵗʰ July, Natera's share was trading at $158.48. NTRA's forward P/E was -130.98 according to Yahoo Finance.
[caption id="attachment_1238861" align="aligncenter" width="768"]The article discusses the revolutionary potential of circulating tumor DNA (ctDNA) in oncology, particularly in the context of cancer treatment and clinical trials. ctDNA tests are becoming more sensitive and information-rich, enabling the...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.